EGFR and cancer: The involvement of EGFR signalling in the induction of pro-tumour immune tolerance has been characterised particularly well for NSCLC, where it has been demonstrated that EGFR+ sEVs can induce differentiation of tolerogenic dendritic cells (DCs), which suppress the anti-cancer immune response [111].